Sharps Technology Begins Shipments Across 3 Customer Orders Under Purchase Agreements

Sharps Technology (NASDAQ: STSS) has initiated commercial shipments across three customer orders, marking its transition to a revenue-generating company. The company delivered its first commercial order of SoloGard syringes under a $50 million supply agreement with a U.S.-based IV flushing solutions leader, starting with a $400,000 order as part of a five-year contract for up to 500 million syringes. Additionally, Sharps shipped SecureGard smart safety syringes worth $100,000 to a Hungarian vaccine provider and commenced delivery of 200,000 units of 1mL low dead space syringes to a Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies. The total initial purchase commitments amount to approximately $500,000. All products are manufactured at the company's upgraded Hungary-based facility, which features advanced molding and automation technologies to support high-volume production.

https://www.stocktitan.net/news/STSS/sharps-technology-begins-shipments-across-three-customer-orders-eigq46xhvega.html